The_DT Major_NP Sites_NP of_IN Cellular_NP Phospholipid_NP Synthesis_NP and_CC Molecular_NP Determinants_NP of_IN Fatty_NP Acid_NP and_CC Lipid_NP Head_NP Group_NP Specificity_NP Phosphatidylcholine_NP and_CC phosphatidylethanolamine_NN are_VBP the_DT two_CD main_JJ phospholipids_NNS in_IN eukaryotic_JJ cells_NNS comprising_VBG similar50_NN and_CC 25_CD %_NN of_IN phospholipid_NN mass_NN ,_, respectively_RB ._SENT Phosphatidylcholine_NP is_VBZ synthesized_VBN almost_RB exclusively_RB through_IN the_DT CDP-choline_NP pathway_NN in_IN essentially_RB all_DT mammalian_JJ cells_NNS ._SENT Phosphatidylethanolamine_NP is_VBZ synthesized_VBN through_IN either_CC the_DT CDP-ethanolamine_NP pathway_NN or_CC by_IN the_DT decarboxylation_NN of_IN phosphatidylserine_NN ,_, with_IN the_DT contribution_NN of_IN each_DT pathway_NN being_VBG cell_NN type_NN dependent_JJ ._SENT Two_CD human_JJ genes_NNS ,_, CEPT1_NP and_CC CPT1_NP ,_, code_NN for_IN the_DT total_JJ compliment_NN of_IN activities_NNS that_WDT directly_RB synthesize_VBP phosphatidylcholine_NN and_CC phosphatidylethanolamine_NN through_IN the_DT CDP-alcohol_NP pathways_NNS ._SENT CEPT1_NP transfers_VBZ a_DT phosphobase_NN from_IN either_DT CDP-choline_NP or_CC CDP-ethanolamine_NP to_TO diacylglycerol_NN to_TO synthesize_VB both_DT phosphatidylcholine_NN and_CC phosphatidylethanolamine_NN ,_, whereas_IN CPT1_NP synthesizes_VBZ phosphatidylcholine_NN exclusively_RB ._SENT We_PP show_VBP through_IN immunofluorescence_NN that_IN brefeldin_NNS A_DT treatment_NN relocalizes_VBZ CPT1_JJ ,_, but_CC not_RB CEPT1_JJ ,_, implying_VBG CPT1_NP is_VBZ found_VBN in_IN the_DT Golgi_NP ._SENT A_DT combination_NN of_IN coimmunofluorescence_NN and_CC subcellular_JJ fractionation_NN experiments_NNS with_IN various_JJ endoplasmic_JJ reticulum_NN ,_, Golgi_NP ,_, and_CC nuclear_JJ markers_NNS confirmed_VBD that_IN CPT1_NP was_VBD found_VBN in_IN the_DT Golgi_NP and_CC CEPT1_NP was_VBD found_VBN in_IN both_CC the_DT endoplasmic_JJ reticulum_NN and_CC nuclear_JJ membranes_NNS ._SENT The_DT rate-limiting_JJ step_NN for_IN phosphatidylcholine_NN synthesis_NN is_VBZ catalyzed_VBN by_IN the_DT amphitropic_JJ CTP:phosphocholine_NP cytidylyltransferase_NN alpha_NN ,_, which_WDT is_VBZ found_VBN in_IN the_DT nucleus_NN in_IN most_JJS cell_NN types_NNS ._SENT CTP:phosphocholine_NP cytidylyltransferase_NN alpha_NN is_VBZ found_VBN immediately_RB upstream_JJ cholinephosphotransferase_NN ,_, and_CC it_PP translocates_VBZ from_IN a_DT soluble_JJ nuclear_JJ location_NN to_TO the_DT nuclear_JJ membrane_NN in_IN response_NN to_TO activators_NNS of_IN the_DT CDP-choline_NP pathway_NN ._SENT Thus_RB ,_, substrate_NN channeling_VBG of_IN the_DT CDP-choline_NP produced_VBD by_IN CTP:phosphocholine_NP cytidylyltransferase_NN alpha_NN to_TO nuclear_JJ located_JJ CEPT1_NN is_VBZ the_DT mechanism_NN by_IN which_WDT upregulation_NN of_IN the_DT CDP-choline_NP pathway_NN increases_VBZ de_NP novo_NP phosphatidylcholine_NN biosynthesis_NN ._SENT In_IN addition_NN ,_, a_DT series_NN of_IN CEPT1_JJ site-directed_JJ mutants_NNS was_VBD generated_VBN that_IN allowed_VBN for_IN the_DT assignment_NN of_IN specific_JJ amino_NN acid_NN residues_NNS as_IN structural_JJ requirements_NNS that_WDT directly_RB alter_VBP either_DT phospholipid_NN head_NN group_NN or_CC fatty_JJ acyl_NN composition_NN ._SENT This_DT pinpointed_JJ glycine_NN 156_CD within_IN the_DT catalytic_JJ motif_NN as_IN being_VBG responsible_JJ for_IN the_DT dual_JJ CDP-alcohol_NP specificity_NN of_IN CEPT1_NP ,_, whereas_IN mutations_NNS within_IN helix_NN 214_CD --_: 228_CD allowed_VBN for_IN the_DT orientation_NN of_IN transmembrane_NN helices_NNS surrounding_VBG the_DT catalytic_JJ site_NN to_TO be_VB definitively_RB positioned_VBN ._SENT Phospholipids_NNS are_VBP the_DT major_JJ components_NNS of_IN cellular_JJ membranes_NNS ._SENT Phosphatidylcholine_NP (_( PtdCho_NP )_) and_CC phosphatidylethanolamine_JJ (_( PtdEtn_NP )_) are_VBP the_DT two_CD most_RBS abundant_JJ phospholipids_NNS present_JJ in_IN eukaryotic_JJ cell_NN membranes_NNS ,_, comprising_VBG similar50_NN and_CC 25_CD %_NN of_IN phospholipid_NN mass_NN ,_, respectively_RB ._SENT Both_DT PtdCho_NP and_CC PtdEtn_NP are_VBP actively_RB metabolized_VBN through_IN both_DT agonist_NN stimulated_VBN and_CC constitutive_JJ processes_NNS to_TO release_VB a_DT plethora_NN of_IN biologically_RB active_JJ molecules_NNS ,_, including_VBG arachidonic_JJ acid_NN for_IN the_DT synthesis_NN of_IN the_DT inflammatory_JJ mediators_NNS prostaglandins_NNS and_CC leukotrienes_NNS ,_, and_CC diacylglycerol_NN for_IN the_DT activation_NN of_IN signaling_VBG molecules_NNS ,_, which_WDT include_VBP members_NNS of_IN the_DT protein_NN kinase_NN C_NP family_NN ._SENT In_IN the_DT face_NN of_IN this_DT complex_JJ metabolic_JJ regulation_NN the_DT levels_NNS of_IN PtdCho_NP and_CC PtdEtn_NP remain_VBP essentially_RB unchanged_JJ ,_, because_IN the_DT cell_NN is_VBZ capable_JJ of_IN responding_VBG to_TO alterations_NNS in_IN lipid_NN catabolism_NN through_IN increases_NNS in_IN synthesis_NN and_CC subsequent_JJ transport_NN of_IN lipids_NNS from_IN their_PP$ site_NN of_IN synthesis_NN to_TO the_DT intracellular_JJ destination_NN at_IN which_WDT the_DT lipid_NN has_VBZ been_VBN catabolized_VBN ._SENT Indeed_RB ,_, in_IN any_DT model_NN of_IN intracellular_JJ lipid_NN homeostasis_NN one_PP must_MD couple_VB lipid_NN metabolism_NN at_IN a_DT particular_JJ site_NN within_IN the_DT cell_NN to_TO increased_VBN de_NP novo_NP lipid_NN synthesis_NN and_CC targeted_JJ transport_NN of_IN the_DT lipid_NN to_TO the_DT site_NN of_IN its_PP$ catabolism_NN ._SENT The_DT regulation_NN of_IN lipid_NN transport_NN may_MD overlap_VB with_IN vesicle_NN trafficking_NN processes_NNS ;_: indeed_RB ,_, the_DT major_JJ cellular_JJ phospholipid_NN PtdCho_NP is_VBZ believed_VBN to_TO be_VB inhibitory_JJ to_TO fission_NN of_IN vesicles_NNS from_IN the_DT Golgi_NP ,_, whereas_IN its_PP$ metabolites_NNS phosphatidic_JJ acid_NN and_CC diacylglycerol_NN appear_VBP to_TO be_VB positive_JJ regulators_NNS of_IN vesicle_NN transport_NN ._SENT Research_NN into_IN the_DT transport_NN of_IN the_DT major_JJ membrane_NN lipids_NNS PtdCho_NP and_CC PtdEtn_NP has_VBZ been_VBN hampered_VBN by_IN a_DT lack_NN of_IN knowledge_NN with_IN regard_NN to_TO precise_JJ sites_NNS of_IN synthesis_NN of_IN these_DT lipids_NNS within_IN the_DT cell_NN ._SENT PtdCho_NP is_VBZ synthesized_VBN almost_RB exclusively_RB through_IN the_DT CDP-choline_NP pathway_NN in_IN all_DT mammalian_JJ cell_NN types_NNS (_( except_IN the_DT liver_NN ;_: Figure_NN ;_: ;_: ;_: )_) ._SENT The_DT first_JJ step_NN in_IN the_DT synthesis_NN of_IN PtdCho_NP through_IN the_DT CDP-choline_NP pathway_NN is_VBZ the_DT phosphorylation_NN of_IN choline_NN by_IN a_DT cytoplasmic_JJ choline_NN kinase_NN to_TO form_VB phosphocholine_NN ._SENT In_IN the_DT second_JJ step_NN ,_, CMP_NN is_VBZ transferred_VBN from_IN CTP_NP to_TO phosphocholine_VB to_TO form_VB CDP-choline_NP by_IN the_DT rate-limiting_JJ CTP:phosphocholine_NP cytidylyltransferase_NN (_( CT_NP )_) ._SENT There_EX are_VBP two_CD isoforms_NNS of_IN CT_NP found_VBD in_IN mammalian_JJ cells_NNS ,_, with_IN CTalpha_NP being_VBG ubiquitous_JJ and_CC likely_RB the_DT major_JJ contributor_NN to_TO PtdCho_NP synthesis_NN in_IN most_JJS cell_NN types_NNS ,_, whereas_IN the_DT second_JJ CT_NP isoform_NN ,_, CTbeta_NP ,_, is_VBZ found_VBN in_IN a_DT much_RB more_RBR restricted_JJ tissue_NN distribution_NN ._SENT ._SENT CTalpha_NP is_VBZ directed_VBN to_TO the_DT nucleus_NN in_IN most_JJS mammalian_JJ cell_NN types_NNS including_VBG the_DT Chinese_JJ hamster_NN ovary_NN cells_NNS (_( CHO_NP )_) cells_NNS used_VBN in_IN this_DT study_NN by_IN a_DT basic_JJ motif_NN found_VBN in_IN its_PP$ N-terminal_JJ region_NN ,_, whereas_IN CTbeta_NP is_VBZ extranuclear_JJ in_IN all_DT cell_NN types_NNS thus_RB far_RB examined_VBN ._SENT The_DT final_JJ step_NN in_IN the_DT synthesis_NN of_IN PtdCho_NP is_VBZ catalyzed_VBN by_IN a_DT cholinephosphotransferase_NN activity_NN that_WDT transfers_VBZ phosphocholine_NN from_IN CDP-choline_NP to_TO diacylglycerol_NN to_TO form_VB PtdCho_NP ._SENT The_DT intracellular_JJ location_NN of_IN the_DT cholinephosphotransferase_NN reaction_NN defines_VBZ the_DT site_NN of_IN PtdCho_NP synthesis_NN ._SENT Figure_NP 1_CD |_SYM Synthesis_NN of_IN PtdCho_NP and_CC PtdEtn_NP by_IN the_DT CDP-alcohol_NP pathways_NNS ._SENT Synthesis_NN of_IN PtdCho_NP and_CC PtdEtn_NP by_IN the_DT CDP-alcohol_NP pathways_NNS ._SENT The_DT gene_NN names_NNS of_IN the_DT enzymes_NNS that_WDT catalyze_VBP each_DT step_NN are_VBP indicated_VBN ._SENT EKI_NP ,_, ethanolamine_NN kinase_NN ;_: ET_NP CTP:phosphocholine_NP cytidylyltransferase_NN ;_: CEPT1_NP ,_, choline/ethanolaminephosphotransferase_NN ;_: CKI_NP ,_, choline_NN kinase_NN ;_: CT_NP ,_, CTP:phosphocholine_NP cytidylyltransferase_NN ;_: CPT1_NP ,_, cholinephosphotransferase_NN ._SENT PtdEtn_NP is_VBZ synthesized_VBN through_IN an_DT analogous_JJ pathway_NN using_VBG a_DT soluble_JJ ethanolamine_NN kinase_NN to_TO produce_VB phosphoethanolamine_NN ,_, which_WDT is_VBZ converted_VBN by_IN an_DT endoplasmic_JJ reticulum_NN bound_VBN CTP:phosphoethanolamine_NP cytidylyltransferase_NN to_TO CDP-ethanolamine_NP ._SENT Phosphoethanolamine_NP is_VBZ transferred_VBN from_IN CDP-ethanolamine_NP to_TO diacylglycerol_NN by_IN an_DT ethanolaminephosphotransferase_NN activity_NN of_IN unknown_JJ intracellular_JJ location_NN to_TO produce_VB PtdEtn_NP ._SENT ._SENT PtdEtn_NP can_MD also_RB be_VB synthesized_VBN by_IN the_DT decarboxylation_NN of_IN phosphatidylserine_NN with_IN the_DT contribution_NN of_IN the_DT CDP-ethanolamine_NP versus_CC phosphatidylserine_JJ decarboxylation_NN pathways_NNS being_VBG cell_NN type_NN dependent_JJ ._SENT Our_PP$ laboratory_NN recently_RB identified_VBD the_DT first_JJ mammalian_JJ cholinephosphotransferase_NN and_CC ethanolaminephosphotransferase_NN encoding_VBG cDNAs_NNS ._SENT CPT1_JJ codes_NNS for_IN a_DT CDP-choline_NP specific_JJ cholinephosphotransferase_NN for_IN the_DT exclusive_JJ synthesis_NN of_IN PtdCho_NP ,_, whereas_IN CEPT1_JJ codes_NNS for_IN a_DT dual_JJ specificity_NN choline/ethanolaminephosphotransferase_NN that_WDT can_MD use_VB both_DT CDP-choline_NP and_CC CDP-ethanolamine_NP as_IN substrates_NNS to_TO synthesize_VB both_DT PtdCho_NP and_CC PtdEtn_NP ._SENT An_DT analysis_NN of_IN the_DT human_JJ genome_NN and_CC those_DT of_IN other_JJ eukaryotic_JJ cells_NNS indicates_VBZ that_IN these_DT two_CD genes_NNS likely_JJ code_NN for_IN the_DT entire_JJ set_NN of_IN cholinephosphotransferases_NNS and_CC ethanolaminephosphotransferases_NNS in_IN mammalian_JJ cells_NNS ._SENT Genetic_JJ inactivation_NN of_IN the_DT analogous_JJ genes_NNS in_IN yeast_NN resulted_VBN in_IN complete_JJ loss_NN of_IN both_DT enzyme_NN activities_NNS in_IN vitro_NN and_CC an_DT inability_NN to_TO metabolically_RB reconstitute_VB lipid_NN synthesis_NN by_IN either_DT route_NN in_IN vivo_RB ._SENT Human_NP CEPT1_NP and_CC CPT1_NP ,_, by_IN virtue_NN of_IN their_PP$ choice_NN in_IN diacylglycerol_NN fatty_JJ acyl_NN and_CC CDP-alcohol_NN species_NNS ,_, affect_VB the_DT form_NN and_CC function_NN of_IN PtdCho_NP and_CC PtdEtn_NP ._SENT In_IN this_DT study_NN we_PP have_VBP pinpointed_VBN the_DT sites_NNS of_IN PtdCho_NP and_CC PtdEtn_NP synthesis_NN in_IN mammalian_JJ cells_NNS ._SENT We_PP have_VBP also_RB taken_VBN advantage_NN of_IN the_DT dual_JJ CDP-alcohol_NP specificity_NN of_IN CEPT1_NP to_TO identify_VB amino_NN acid_NN residues_NNS that_WDT determine_VBP its_PP$ ability_NN to_TO synthesize_VB PtdCho_NP versus_CC PtdEtn_NP and_CC have_VBP identified_VBN amino_NN acid_NN residues_NNS that_WDT alter_VBP its_PP$ diacylglycerol_NN fatty_JJ acyl_NN species_NN preference_NN ._SENT Materials_NPS |_SYM [_SYM Methyl-14C]Cytidine_NP 5'-diphosphocholine_NP and_NP [_SYM ethanolamine_NN 1,2-14C]cytidine_JJ 5'-diphosphoethanolamine_NN were_VBD purchased_VBN from_IN American_NP Radiolabeled_NP Chemicals_NPS (_( St._NP Louis_NP ,_, MO_NP )_) ._SENT [_SYM Methyl-14C]-choline_NP chloride_NN was_VBD purchased_VBN from_IN NEN_NP Life_NP Science_NP Products_NPS (_( Boston_NP ,_, MA_NP )_) ._SENT [_SYM Ethanolamine_JJ 1,2-14C]-ethanolamine_JJ hydrochloride_NN was_VBD purchased_VBN from_IN ICN_NP (_( Costa_NP Mesa_NP ,_, CA_NP )_) ._SENT All_DT materials_NNS used_VBN in_IN the_DT preparation_NN of_IN bacterial_JJ and_CC yeast_NN media_NNS were_VBD purchased_VBN from_IN Difco_NP Laboratories_NPS (_( Detroit_NP ,_, MI_NP )_) ._SENT Lipids_NNS were_VBD purchased_VBN from_IN Avanti_NP Polar_NP Lipids_NP (_( Birmingham_NP ,_, AL_NP )_) ._SENT The_DT T7_JJ mouse_NN mAb_NN and_CC T7_JJ mouse_NN mAb_NN conjugated_VBN to_TO horseradish_NN peroxidase_NN were_VBD purchased_VBN from_IN Novagen_NP (_( Madison_NP ,_, WI_NP )_) ._SENT The_DT anticalnexin_NN rabbit_NN polyclonal_JJ antibody_NN was_VBD a_DT product_NN of_IN StressGen_NP Biotechnologies_NP Corp_NP (_( Victoria_NP ,_, British_NP Columbia_NP ,_, Canada_NP )_) ._SENT The_DT Lap-2_NP mouse_NN mAb_NN was_VBD purchased_VBN from_IN Transduction_NP Laboratories_NPS (_( Lexington_NP ,_, KY_NP )_) ._SENT The_DT CTalpha_NP rabbit_NN polyclonal_JJ antibody_NN was_VBD a_DT gift_NN from_IN Dr._NP Martin_NP Post_NP (_( Hospital_NP for_IN Sick_NP Children_NP ,_, Toronto_NP ,_, Canada_NP )_) ._SENT FITC-labeled_NP Lens_NP culinaris_NP (_( LcH_NP )_) lectin_NN was_VBD purchased_VBN from_IN Sigma_NP (_( St._NP Louis_NP ,_, MO_NP )_) ._SENT Goat_NN anti-mouse_NN Texas_NP Red_NP ,_, goat_NN anti-rabbit_NN Texas_NP Red_NP ,_, goat_NN anti-mouse_NN FITC_NP ,_, and_CC goat_NN anti-rabbit_NN FITC_NP secondary_JJ antibodies_NNS were_VBD products_NNS of_IN Molecular_NP Probes_NP (_( Eugene_NP ,_, OR_NP )_) ._SENT Generation_NN of_IN Constructs_NP for_IN Expression_NP in_IN Mammalian_NP Cells_NP |_SYM Human_NP CEPT1_NP was_VBD amplified_VBN by_IN PCR_NP from_IN our_PP$ original_JJ cDNA_NN using_VBG the_DT oligonucleotide_NN primers_NNS ,_, 5'-GCGGGATCCATGAGTGGGCATCGATCAACA-3_NP '_POS (_( forward_RB )_) and_CC 5'-GCGGTCGACTTAATGATTAGAATGAGCTGT-3_NP '_POS (_( reverse_NN )_) ,_, which_WDT contain_VBP BamHI_NP and_CC SalI_NP restriction_NN sites_NNS ,_, respectively_RB ._SENT The_DT PCR_NP product_NN was_VBD subcloned_VBN into_IN the_DT pCR2.1-Topo_NN vector_NN (_( Invitrogen_NP ,_, Carlsbad_NP ,_, CA_NP )_) ,_, excised_VBN with_IN BamHI_NP and_CC SalI_NP and_CC subcloned_VBN into_IN the_DT Escherichia_NP coli_NNS expression_NN vector_NN pET23a_NP (_( Novagen_NP )_) ,_, resulting_VBG in_IN the_DT addition_NN of_IN an_DT 11-residue_JJ ,_, T7_JJ epitope_NN tag_NN to_TO the_DT N-terminus_NN of_IN the_DT protein_NN ._SENT The_DT T7-tagged_JJ version_NN of_IN CEPT1_NP was_VBD excised_VBN using_VBG BglII_NP and_CC SalI_NP and_CC subcloned_VBN into_IN the_DT BamHI_NP and_CC SalI_NP sites_NNS of_IN the_DT mammalian_JJ expression_NN vector_NN pcDNA3_NN (_( Invitrogen_NP )_) ._SENT GFP_NP was_VBD added_VBN to_TO the_DT C_NP terminus_NN of_IN T7-tagged_NP CEPT1_NP by_IN amplification_NN of_IN CEPT1_NP by_IN PCR_NP using_VBG the_DT oligonucleotide_NN primers_NNS ,_, 5'-GCAAGATCTATGGCTAGCATGACTGGTGGA-3_NP '_POS (_( forward_RB )_) and_CC 5'-GCGCAGAATTCGATGATGATTAGAATGAGC-3_NP '_POS (_( reverse_NN )_) ,_, which_WDT have_VBP BglII_NP and_CC EcoRI_NP restriction_NN sites_NNS ,_, respectively_RB ,_, built_VBN into_IN the_DT primers_NNS ,_, and_CC subcloned_VBD into_IN the_DT BglII_NP and_CC EcoRI_NP sites_NNS of_IN the_DT mammalian_JJ expression_NN vector_NN pEGFP-N1_NN (_( ,_, Palo_NP Alto_NP ,_, CA_NP )_) ._SENT Expression_NN of_IN this_DT construct_NN in_IN mammalian_JJ cells_NNS results_NNS in_IN the_DT production_NN of_IN a_DT CEPT1_JJ protein_NN with_IN an_DT N-terminal_JJ T7_JJ epitope_NN tag_NN and_CC a_DT C-terminal_JJ green_JJ fluorescent_JJ protein_NN (_( GFP_NP )_) ._SENT The_DT open_JJ reading_NN frame_NN of_IN human_JJ CPT1_NP was_VBD amplified_VBN by_IN PCR_NP using_VBG the_DT oligonucleotide_NN primers_NNS 5'-GCCAGATCTATGGCGGCGGCGCCGGGGCC-3_NN '_'' (_( forward_RB )_) and_CC 5'-GCCGTCGACTCAATCCATGTTATTCTGATG-3_NP '_POS (_( reverse_NN )_) ,_, which_WDT have_VBP BglII_NP and_CC SalI_NP restriction_NN sites_NNS ,_, respectively_RB ,_, and_CC subcloning_VBG into_IN the_DT TA_NP cloning_VBG into_IN the_DT pCR2.1-TOPO_NP (_( Invitrogen_NP )_) ._SENT The_DT BglII/SalI_NP fragment_NN was_VBD excised_VBN and_CC subcloned_VBN into_IN the_DT BamHI_NP and_CC SalI_NP sites_NNS of_IN the_DT pET23a_NN vector_NN ,_, resulting_VBG in_IN the_DT addition_NN of_IN a_DT T7_JJ epitope_NN tag_NN to_TO the_DT N-terminus_NP of_IN CPT1_NP ._SENT The_DT T7-tagged_JJ version_NN of_IN CPT1_NP was_VBD digested_VBN with_IN BglII_NP and_CC NotI_NP and_CC subcloned_VBN into_IN the_DT BamHI_NP and_CC NotI_NP restriction_NN sites_NNS of_IN pcDNA3_NN (_( Invitrogen_NP )_) ._SENT The_DT DNA_NP sequence_NN of_IN all_DT PCR-amplified_JJ constructs_NNS was_VBD confirmed_VBN by_IN sequencing_NP both_CC DNA_NP strands_NNS ._SENT Site-directed_JJ mutants_NNS were_VBD made_VBN using_VBG the_DT MORPH_NP site-directed_JJ mutagenesis_NN kit_NN (_( 5_CD Prime_NP 3_CD Prime_NP ,_, Inc._NP ,_, West_NP Chester_NP ,_, PA_NP )_) ._SENT Mutagenic_JJ oligonucleotides_NNS were_VBD 5'-phosphorylated_JJ and_CC purchased_VBN from_IN Life_NP Technologies_NPS (_( Rockville_NP ,_, MD_NP )_) ._SENT Mutations_NNS were_VBD confirmed_VBN by_IN manual_JJ dideoxy_NNS sequencing_VBG using_VBG the_DT T7sequencing_JJ kit_NN (_( Amersham_NP Pharmacia_NP Biotech_NP ,_, Piscataway_NP ,_, NJ_NP )_) ._SENT Cell_NN Culture_NP |_SYM CHO-K1_JJ cells_NNS were_VBD transiently_RB transfected_VBN using_VBG LIPOFECTAMINE_NP Reagent_NP (_( Life_NP Technologies_NPS )_) in_IN DMEM_NP containing_VBG 5_CD %_NN (_( vol/vol_NN )_) fetal_JJ calf_NN serum_NN and_CC 33_CD mug/ml_NN proline_NN and_CC maintained_VBN at_IN 37C_JJ in_IN an_DT atmosphere_NN of_IN 5_CD %_NN CO2_NN ._SENT The_DT calcium_NN chloride_NN method_NN of_IN cell_NN transfection_NN was_VBD used_VBN for_IN the_DT preparation_NN of_IN stable_JJ cell_NN lines_NNS in_IN 100-mm_NP dishes_NNS ._SENT Transfected_JJ cells_NNS were_VBD incubated_VBN overnight_RB at_IN 37C_JJ in_IN DMEM_NP containing_VBG 5_CD %_NN (_( vol/vol_NN )_) fetal_JJ calf_NN serum_NN and_CC 33_CD mug/ml_NN proline_NN ._SENT Medium_NN was_VBD replaced_VBN with_IN 8_CD ml_NN of_IN CHO-K1_JJ media_NNS containing_VBG 500_CD mug/ml_NN G418_NP to_TO start_VB selection_NN of_IN stably_RB transfected_JJ clones_NNS ._SENT Subsequently_RB ,_, the_DT medium_NN was_VBD replaced_VBN every_DT 2_CD --_: 3_CD d_NN with_IN 8_CD ml_NN of_IN fresh_JJ CHO-K1_JJ medium_NN containing_VBG 500_CD mug/ml_NN G418_NP to_TO select_VB for_IN clones_NNS that_WDT were_VBD stably_RB transfected_VBN with_IN the_DT desired_VBN plasmid_NN ._SENT Single_JJ colonies_NNS of_IN stably_RB transfected_JJ CHO-K1_JJ cells_NNS were_VBD selected_VBN by_IN dilution_NN cloning_VBG ._SENT Positive_JJ colonies_NNS were_VBD initially_RB identified_VBN by_IN Western_NP blotting_VBG with_IN the_DT T7-horseradish_NP peroxidase_NN --_: conjugated_JJ antibody_NN and_CC their_PP$ homogeneity_NN confirmed_VBD by_IN immunofluorescence_NN ._SENT Immunofluorescence_NN |_SYM All_DT cells_NNS used_VBN for_IN immunofluorescence_NN were_VBD grown_VBN on_IN glass_NN coverslips_NNS in_IN 60-mm_JJ dishes_NNS at_IN a_DT density_NN of_IN 2_CD x_NN 105_CD cells_NNS per_IN dish_NN ._SENT Cells_NNS were_VBD fixed_VBN in_IN 3_CD %_NN (_( vol/vol_NN )_) formaldehyde_NN in_IN 10_CD mM_NP sodium_NN phosphate_NN (_( pH_NN 7.4_CD )_) ,_, 225_CD mM_NP NaCl_NP ,_, 2_CD mM_NP MgCl2_NP (_( PBS-B_NP )_) for_IN 15_CD min_NN at_IN room_NN temperature_NN ._SENT The_DT coverslips_NNS were_VBD washed_VBN twice_RB at_IN room_NN temperature_NN with_IN PBS-B_NN containing_VBG 5_CD mM_NP ammonium_NN chloride_NN for_IN 5_CD min_NN each_DT wash_NN ,_, with_IN PBS-B_NN for_IN 5_CD min_NN ,_, and_CC then_RB permeabilized_VBN by_IN adding_VBG PBS-B_NN containing_VBG 0.05_CD %_NN Triton_NP X-100_NP and_CC incubating_VBG at_IN 40C_JJ for_IN 15_CD min_NN and_CC then_RB room_NN temperature_NN for_IN 15_CD min_NN ._SENT The_DT coverslips_NNS were_VBD washed_VBN twice_RB with_IN PBS-B_NN containing_VBG 1_CD %_NN fatty_JJ acid_NN --_: free_JJ BSA_NP (_( PBS/BSA_NP )_) for_IN 5_CD min_NN per_IN wash_NN ,_, once_RB for_IN 15_CD min_NN ,_, and_CC treated_VBN with_IN primary_JJ antibody_NN in_IN PBS/BSA_NP for_IN 1_CD h_NN at_IN room_NN temperature_NN ._SENT The_DT coverslips_NNS were_VBD washed_VBN twice_RB with_IN PBS/BSA_NP for_IN 5_CD min_NN each_DT ._SENT LcH-lectin_NP (_( which_WDT was_VBD conjugated_VBN directly_RB to_TO FITC_NP )_) and_CC secondary_JJ antibody_NN was_VBD added_VBN in_IN PBS/BSA_NP ,_, and_CC cells_NNS were_VBD incubated_VBN for_IN 1_CD h_NN at_IN room_NN temperature_NN and_CC washed_VBD twice_RB with_IN PBS/BSA_NP for_IN 5_CD min_NN each_DT ,_, and_CC the_DT coverslips_NNS were_VBD mounted_VBN on_IN slides_NNS with_IN 2.5_CD %_NN (_( wt/vol_NN )_) 1,4-diazadicyclo-[2,2,2]-octane_JJ in_IN 50_CD mM_NP Tris-HCl_NP (_( pH_NN 9.0_CD )_) and_CC 90_CD %_NN (_( vol/vol_NN )_) glycerol_NN ._SENT T7_JJ antibodies_NNS were_VBD used_VBN at_IN 1:1000_CD dilution_NN ,_, CTalpha_NP antibodies_NNS at_IN 1:4000_CD ,_, and_CC calnexin_NN antibodies_NNS at_IN 1:200_CD ._SENT Secondary_JJ antibodies_NNS and_CC FITC-coupled_NP LcH-lectin_NP were_VBD used_VBN at_IN a_DT 1:4000_CD dilution_NN ._SENT Very_RB faint_VB intranuclear_JJ staining_VBG was_VBD observed_VBN with_IN the_DT T7_JJ mAb_NN in_IN mock-transfected_JJ cells_NNS ._SENT To_TO stain_VB the_DT mitochondria_NNS ,_, cells_NNS were_VBD grown_VBN on_IN glass_NN coverslips_NNS as_RB described_VBD above_IN ._SENT Before_IN fixing_VBG ,_, the_DT medium_NN was_VBD aspirated_VBN from_IN the_DT cells_NNS and_CC replaced_VBN with_IN fresh_JJ CHO-K1_JJ medium_NN containing_VBG 200_CD nM_NN MitoTracker_NP Red_NP CMXRos_NP (_( Molecular_NP Probes_NP )_) ._SENT The_DT cells_NNS were_VBD incubated_VBN with_IN the_DT dye_NN for_IN 45_CD min_NN at_IN 37C_JJ and_CC washed_VBN twice_RB with_IN warm_JJ PBS_NP ._SENT Cells_NNS were_VBD fixed_VBN and_CC mounted_VBN as_IN described_VBN above_IN ._SENT Cells_NNS transiently_RB transfected_VBN with_IN GFP-fusion_NP and_CC YFP-fusion_NP proteins_NNS were_VBD grown_VBN on_IN glass_NN coverslips_NNS ,_, washed_VBD three_CD times_NNS with_IN 58_CD mM_NP Na2HPO4_NP ,_, 17_CD mM_NP NaH2PO4_NP ,_, 68_CD mM_NP NaCl_NP (_( PBS-C_NP ,_, pH_NN 7.4_CD )_) ,_, and_CC either_RB viewed_VBN directly_RB or_CC fixed_VBN by_IN incubating_VBG with_IN PBS-C/4_NP %_NN formaldehyde_NN for_IN 30_CD min_NN at_IN room_NN temperature_NN ,_, washed_VBN twice_RB with_IN PBS-C_NP ,_, and_CC mounted_VBD as_RB described_VBN above_IN ._SENT The_DT YFP-Golgi_NP marker_NN is_VBZ a_DT fusion_NN protein_NN consisting_VBG of_IN enhanced_JJ yellow_JJ fluorescent_JJ protein_NN and_CC the_DT sequence_NN encoding_VBG the_DT N-terminal_JJ 81_CD amino_NN acids_NNS of_IN human_JJ beta-1,4-galactosyltransferase_NN ._SENT Fluorescence_NN microscopy_NN was_VBD performed_VBN using_VBG a_DT Zeiss_NP axiophot_NN microscope_NN (_( Thornwood_NP ,_, NY_NP )_) ._SENT Green_JJ and_CC yellow_JJ fluorescent_JJ proteins_NNS and_CC FITC-coupled_JJ antibodies_NNS were_VBD visualized_VBN with_IN Zeiss_NP filter_NN number_NN 10_CD ,_, which_WDT excites_VBZ at_IN 450/490_CD and_CC emits_VBZ at_IN 550/565_CD ._SENT Texas_NP Red_NP and_CC MitoTracker_NP were_VBD visualized_VBN with_IN Zeiss_NP filter_NN number_NN 15_CD ,_, which_WDT excites_VBZ at_IN 546/560_CD and_CC emits_VBZ at_IN 590_CD ._SENT Nuclear_NP Fraction_NP Isolation_NP |_SYM NE-PER_NP Nuclear_NP and_CC Cytoplasmic_NP Extraction_NP Reagents_NP Kit_NP (_( ,_, Rockford_NP ,_, IL_NP )_) was_VBD used_VBN to_TO isolate_VB nuclei_NNS ._SENT We_PP seeded_VBD 5_CD x_SYM 105_CD CHO_NP cells_NNS in_IN a_DT 100-mm_NP plate_NN containing_VBG DMEM_NP with_IN 5_CD %_NN (_( vol/vol_NN )_) fetal_JJ calf_NN serum_NN and_CC 33_CD mug/ml_NN proline_NN and_CC maintained_VBN at_IN 37C_JJ ._SENT The_DT cells_NNS were_VBD maintained_VBN in_IN an_DT atmosphere_NN of_IN 5_CD %_NN CO2_NN for_IN 4_CD d._NN The_DT plates_NNS were_VBD placed_VBN on_IN ice_NN ,_, and_CC the_DT medium_NN was_VBD aspirated_VBN ._SENT The_DT cells_NNS were_VBD scraped_VBN into_IN 1_CD ml_NN ice-cold_JJ PBS_NP and_CC spun_VBN at_IN 500_CD x_NN g_NN at_IN 4C_JJ for_IN 3_CD min_NN ._SENT The_DT PBS_NP was_VBD aspirated_VBN ,_, and_CC the_DT cell_NN pellet_NN was_VBD resuspended_VBN in_IN 200_CD mul_NN cytoplasmic_JJ extraction_NN reagent_NN I._NN The_DT sample_NN was_VBD vortexed_VBN at_IN the_DT highest_JJS setting_NN for_IN 15_CD s_NN to_TO fully_RB resuspend_VB the_DT cell_NN pellet_NN ._SENT The_DT sample_NN was_VBD incubated_VBN on_IN ice_NN for_IN 10_CD min_NN ,_, and_CC 11_CD mul_NN cytoplasmic_JJ extraction_NN reagent_NN II_NP was_VBD added_VBN ._SENT The_DT sample_NN was_VBD vortexed_JJ 5_CD s_NNS and_CC incubated_VBN on_IN ice_NN for_IN 1_CD min_NN ._SENT The_DT sample_NN was_VBD vortexed_JJ 5_CD s_NNS on_IN the_DT highest_JJS setting_NN and_CC then_RB spun_VBN at_IN 16,000_CD x_NN g_NN and_CC 4C_JJ for_IN 5_CD min_NN ._SENT The_DT supernatant_JJ was_VBD transferred_VBN to_TO a_DT new_JJ ,_, precooled_JJ tube_NN and_CC mixed_VBN with_IN an_DT equal_JJ volume_NN of_IN SDS-loading_NP buffer_NN ._SENT The_DT pellet_NN was_VBD resuspended_VBN in_IN 100_CD mul_NN nuclear_JJ extraction_NN reagent_NN ._SENT The_DT sample_NN was_VBD vortexed_VBN for_IN 15_CD s_NNS and_CC incubated_VBN on_IN ice_NN for_IN 10_CD min_NN ._SENT This_DT was_VBD repeated_VBN for_IN a_DT total_NN of_IN 40_CD min_NN ._SENT The_DT sample_NN was_VBD spun_VBN at_IN 16,000_CD x_NN g_NN and_CC 4C_JJ for_IN 10_CD min_NN ._SENT The_DT supernatant_JJ was_VBD transferred_VBN to_TO a_DT new_JJ ,_, precooled_JJ tube_NN and_CC then_RB mixed_VBN with_IN an_DT equal_JJ volume_NN of_IN SDS-loading_NP buffer_NN ._SENT Samples_NNS were_VBD stored_VBN at_IN -20C_NN ._SENT A_DT 20-mul_JJ sample_NN of_IN nuclear_JJ and_CC extranuclear_JJ extracts_VBZ was_VBD loaded_VBN and_CC proteins_NNS separated_VBN by_IN SDS-PAGE_NP and_CC identified_VBN by_IN Western_JJ blot_NN ._SENT Western_NP Blot_NP Analysis_NP |_SYM HJ091_JJ Saccharomyces_NP cerevisiae_NNS cells_NNS (_( ahis3-Delta1_JJ leu2-3_NN leu2-112_NN ura3-52_JJ trp1_NN --_: 289_CD cpt1::LEU2_NN ept1-_NN )_) were_VBD grown_VBN to_TO midlog_NN phase_NN in_IN synthetic_JJ dextrose_NN medium_NN containing_VBG the_DT appropriate_JJ nutrients_NNS to_TO ensure_VB plasmid_NN maintenance_NN ,_, and_CC microsomal_JJ membranes_NNS were_VBD prepared_VBN as_IN described_VBN ._SENT Protein_NN extracts_VBZ were_VBD incubated_VBN with_IN SDS-PAGE_NP sample_NN buffer_NN at_IN 37C_JJ for_IN 30_CD min_NN ,_, separated_VBN on_IN a_DT 12_CD %_NN SDS-polyacrylamide_NN gel_NN ,_, and_CC transferred_VBD to_TO polyvinylidene_VB difluoride_NN membranes_NNS ._SENT Blots_NNS were_VBD probed_VBN with_IN a_DT T7_JJ epitope_NN tag-specific_JJ mAb_NN coupled_VBN directly_RB to_TO horseradish_NN peroxidase_NN (_( 1:5000_CD ,_, Novagen_NP )_) for_IN subsequent_JJ detection_NN using_VBG the_DT ECL_NN system_NN (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ._SENT Enzyme_NN Assays_NNS |_SYM To_TO determine_VB in_IN vitro_NN choline-_NN and_CC ethanolaminephosphotransferase_NN enzyme_NN activities_NNS of_IN wild-type_NN and_CC site-directed_JJ CEPT1_JJ mutants_NNS the_DT microsomal_JJ membranes_NNS were_VBD isolated_VBN from_IN HJ091_JJ yeast_NN (_( cpt1::LEU2_JJ ept1-_NN )_) grown_VBN to_TO midlog_NN phase_NN in_IN synthetic_JJ dextrose_NN media_NNS containing_VBG the_DT appropriate_JJ nutrients_NNS to_TO ensure_VB plasmid_NN maintenance_NN of_IN wild-type_NN or_CC mutant_JJ versions_NNS of_IN CEPT1_NP from_IN the_DT constitutive_JJ glyceraldehyde-3-phosphate_NN dehydrogenase_NN promoter_NN in_IN the_DT expression_NN vector_NN p416GPD_NNS ._SENT A_DT mixed_JJ micelle_NN assay_NN was_VBD used_VBN as_IN previously_RB described_VBN ._SENT All_DT assays_NNS were_VBD performed_VBN at_IN least_JJS three_CD times_NNS in_IN duplicate_NN and_CC the_DT indicated_JJ values_NNS represent_VBP their_PP$ mean_NN ._SENT SEs_NNS were_VBD <15_JJ %_NN of_IN the_DT mean_NN for_IN each_DT experiment_NN ._SENT Cholinephosphotransferase_NN and_CC ethanolaminephosphotransferase_NN activities_NNS in_IN CHO-K1_JJ cell_NN lines_NNS and_CC CHO-K1_JJ cells_NNS transiently_RB transfected_VBN with_IN CEPT1-GFP_NP were_VBD determined_VBN after_IN placing_VBG the_DT cells_NNS on_IN ice_NN and_CC washing_VBG them_PP twice_RB with_IN ice-cold_JJ PBS_NP ._SENT The_DT cells_NNS were_VBD scraped_VBN into_IN a_DT microfuge_NN and_CC centrifuged_VBN at_IN 15,000_CD x_NN g_NN for_IN 5_CD min_NN at_IN 4C_JJ ._SENT The_DT cell_NN pellet_NN was_VBD resuspended_VBN in_IN 0.5_CD ml_NN of_IN 10_CD mM_NP HEPES-HCl_NP (_( pH_NN 7.4_CD )_) ,_, 50_CD mM_NP KCl_NP ,_, 1_CD mM_NP EDTA_NP ,_, and_CC Complete_JJ protease_NN inhibitor_NN cocktail_NN (_( Roche_NP Molecular_NP Biochemicals_NP ,_, Indianapolis_NP ,_, IN_IN )_) )_) and_CC passed_VBN through_IN a_DT 23-gauge_JJ needle_NN 20_CD times_NNS to_TO lyse_VB the_DT cells_NNS ._SENT The_DT mixture_NN was_VBD centrifuged_VBN at_IN 15,000_CD x_NN g_NN for_IN 30_CD s_NNS at_IN 4C_JJ ,_, and_CC the_DT supernatant_JJ was_VBD centrifuged_VBN at_IN 450,000_CD x_NN g_NN for_IN 15_CD min_NN at_IN 4C_JJ to_TO pellet_VB cellular_JJ membranes_NNS ._SENT Membranes_NNS were_VBD resuspended_VBN in_IN 10_CD mM_NP HEPES-HCl_NP (_( pH_NN 7.4_CD )_) ,_, 50_CD mM_NP KCl_NP ,_, 1_CD mM_NP EDTA_NP ,_, and_CC Complete_JJ protease_NN inhibitor_NN cocktail_NN (_( Roche_NP Molecular_NP Biochemicals_NP )_) by_IN using_VBG a_DT Teflon_NP pestle_NN and_CC stored_VBD at_IN -70C_NN ._SENT The_DT mixed_JJ micelle_NN assay_NN for_IN cholinephosphotransferase_NN activity_NN was_VBD used_VBN as_IN previously_RB described_VBN ._SENT Metabolic_JJ Labeling_NN |_SYM S._NP cerevisiae_NNS HJ091_NP cells_NNS (_( cpt1::LEU2_JJ ept1-_NN )_) transformed_VBN with_IN either_DT wild-type_NN or_CC mutant_JJ versions_NNS of_IN CEPT1_NP in_IN the_DT constitutive_JJ expression_NN vector_NN p416GPD_NNS were_VBD grown_VBN to_TO midlog_NN phase_NN in_IN synthetic_JJ dextrose_NN media_NNS containing_VBG the_DT appropriate_JJ nutrients_NNS to_TO ensure_VB plasmid_NN maintenance_NN ._SENT [_SYM 14C]Choline_JJ (_( 10_CD muM_NN ,_, 1_CD x_SYM 105_CD dpm/nmol_NN )_) or_CC [_SYM 14C]ethanolamine_JJ (_( 6.7_CD muM_NN ,_, 2.2_CD x_SYM 105_CD dpm/nmol_NN )_) was_VBD added_VBN to_TO the_DT cultures_NNS for_IN 1_CD h_NN at_IN 30C_JJ ._SENT Cells_NNS were_VBD then_RB concentrated_VBN by_IN centrifugation_NN and_CC incorporation_NN of_IN radiolabel_NN into_IN lipids_NNS was_VBD performed_VBN as_IN described_VBN ._SENT All_DT labeling_VBG experiments_NNS were_VBD performed_VBN at_IN least_JJS three_CD times_NNS in_IN duplicate_NN and_CC the_DT values_NNS indicated_VBD represent_VB their_PP$ mean_NN ._SENT SEs_NNS were_VBD <15_JJ %_NN of_IN the_DT mean_NN for_IN each_DT experiment_NN ._SENT Protein_NN and_CC Lipid_NP Determination_NP |_SYM Protein_NP was_VBD determined_VBN by_IN the_DT method_NN of_IN using_VBG bovine_JJ serum_NN albumin_NN as_IN standard_NN ._SENT Phospholipid_NN phosphorus_NN was_VBD determined_VBN by_IN the_DT method_NN of_IN ._SENT Sites_NNS of_IN PtdCho_NP and_CC PtdEtn_NP Synthesis_NP |_SYM The_DT CEPT1_JJ open_JJ reading_NN frame_NN was_VBD fused_VBN with_IN that_DT of_IN the_DT GFP_NP ,_, and_CC this_DT construct_NN was_VBD transiently_RB transfected_VBN into_IN Chinese_JJ hamster_NN ovary_NN (_( CHO-K1_JJ )_) cells_NNS ._SENT The_DT CEPT1-GFP_NP chimeric_JJ protein_NN was_VBD functional_JJ as_IN cells_NNS transiently_RB transfected_VBN with_IN CEPT1-GFP_NP at_IN 20_CD %_NN efficiency_NN had_VBD a_DT fourfold_JJ increase_NN in_IN cholinephosphotransferase_NN activity_NN ._SENT Indeed_RB ,_, transfection_NN efficiency_NN of_IN CEPT1-GFP_NP essentially_RB mirrored_VBD the_DT increase_NN in_IN cholinephosphotransferase_NN activity_NN ,_, implying_VBG that_IN all_DT of_IN the_DT CEPT1-GFP_NP fusion_NN protein_NN was_VBD enzymatically_RB active_JJ (_( our_PP$ unpublished_JJ results_NNS )_) ._SENT As_IN an_DT initial_JJ step_NN in_IN determining_VBG the_DT intracellular_JJ site_NN of_IN CEPT1_NP we_PP treated_VBD the_DT cells_NNS with_IN brefeldin_NP A_NP ,_, which_WDT essentially_RB collapses_VBZ the_DT Golgi_NP apparatus_NN into_IN the_DT endoplasmic_JJ reticulum_NN ,_, resulting_VBG in_IN a_DT dramatic_JJ relocalization_NN of_IN most_JJS Golgi_NP resident_NN proteins_NNS ._SENT Brefeldin_NP A_NP treatment_NN did_VBD not_RB result_VB in_IN the_DT relocalization_NN of_IN CEPT1_NP ,_, whereas_IN the_DT Golgi_NP marker_NN was_VBD effectively_RB relocalized_JJ (_( Figure_NP A_NP )_) ._SENT Similar_JJ results_NNS were_VBD observed_VBN whether_IN live_JJ cells_NNS were_VBD viewed_VBN or_CC if_IN cells_NNS were_VBD fixed_VBN before_IN microscopy_NN (_( our_PP$ unpublished_JJ results_NNS )_) ._SENT Figure_NP 2_CD |_SYM Effect_NN of_IN brefeldin_NP A_NP on_IN CEPT1_NP and_CC CPT1_NP subcellular_JJ localization_NN ._SENT Effect_NN of_IN brefeldin_NP A_NP on_IN CEPT1_NP and_CC CPT1_NP subcellular_JJ localization_NN ._SENT (_( A_NP )_) CHO-K1_NP cells_NNS transiently_RB transfected_VBN with_IN T7-CEPT1-GFP_NP or_CC the_DT first_JJ 81_CD amino_NN of_IN the_DT Golgi_NP resident_NN beta-1,4-galactosyltransferase_NN fused_VBN to_TO yellow_JJ fluorescent_JJ protein_NN were_VBD treated_VBN with_IN 2_CD mug/ml_NN brefeldin_NN A_DT for_IN 30_CD min_NN ._SENT Live_JJ and_CC fixed_VBN cells_NNS resulted_VBN in_IN identical_JJ images_NNS ._SENT (_( B_LS )_) CHO-K1_JJ cells_NNS stably_RB expressing_VBG T7-CPT1_NP were_VBD treated_VBN with_IN brefeldin_NP A_NP and_CC T7_JJ monoclonal_NN antibodies_NNS followed_VBN by_IN Texas_NP Red_NP --_: conjugated_JJ secondary_JJ antibodies_NNS were_VBD used_VBN to_TO determine_VB the_DT location_NN of_IN CPT1_NP ._SENT The_DT location_NN of_IN the_DT Golgi_NP was_VBD determined_VBN by_IN the_DT addition_NN of_IN FITC-coupled_NP L._NP culinaris_NN lectin_NN ._SENT To_TO further_RBR define_VB the_DT intracellular_JJ site_NN of_IN CEPT1_NP and_CC CPT1_NP ,_, stable_JJ CHO-K1_JJ cell_NN lines_NNS expressing_VBG T7-epitope_NP --_: tagged_VBN CEPT1_NP and_CC CPT1_NP were_VBD constructed_VBN ._SENT These_DT same_JJ T7-tagged_NP CEPT1_NP and_CC CPT1_NP proteins_NNS expressed_VBD in_IN yeast_NN devoid_JJ of_IN their_PP$ endogenous_JJ cholinephosphotransferase_NN and_CC ethanolaminephosphotransferase_NN activities_NNS were_VBD previously_RB used_VBN to_TO characterize_VB the_DT substrate_NN specificity_NN of_IN the_DT CEPT1_JJ and_CC CPT1_JJ enzymes_NNS in_IN vitro_NN by_IN enzyme_NN assay_NN and_CC in_IN vivo_RB through_IN metabolic_JJ labeling_VBG experiments_NNS ._SENT In_IN addition_NN ,_, increased_VBD expression_NN of_IN T7-tagged_NP CEPT1_NP was_VBD demonstrated_VBN to_TO prevent_VB farnesol_NN induced_VBN inhibition_NN of_IN cholinephosphotransferase_NN activity_NN in_IN CHO-K1_JJ cells_NNS ,_, once_RB again_RB demonstrating_VBG that_IN the_DT tagged_VBN versions_NNS of_IN these_DT enzymes_NNS are_VBP active_JJ and_CC can_MD reconstitute_VB the_DT CDP-alcohol_NP pathways_NNS in_IN a_DT variety_NN of_IN eukaryotic_JJ cell_NN types_NNS ,_, indicating_VBG they_PP are_VBP properly_RB localized_VBN ._SENT We_PP isolated_VBD five_CD CHO-K1_JJ cell_NN lines_NNS expressing_VBG T7-tagged_NP CEPT1_NP or_CC CPT1_NP that_WDT possessed_VBD barely_RB perceptible_JJ increases_NNS in_IN CEPT1_NP and_CC CPT1_NP enzyme_NN activity_NN compared_VBN with_IN those_DT with_IN up_RB to_TO fivefold_RB increased_VBN expression_NN of_IN CPT1_NP or_CC CEPT1_NP ._SENT We_PP found_VBD that_IN the_DT level_NN of_IN expression_NN of_IN CPT1_NP and_CC CEPT1_NP did_VBD not_RB alter_VB their_PP$ intracellular_JJ locations_NNS (_( our_PP$ unpublished_JJ results_NNS )_) ,_, and_CC representative_JJ images_NNS of_IN cell_NN lines_NNS with_IN an_DT estimated_JJ twofold_JJ increase_NN in_IN CEPT1_NP and_CC CPT1_NP expression_NN are_VBP presented_VBN (_( Figures_NNS and_CC )_) ._SENT Figure_NP 3_CD |_SYM Intracellular_JJ localization_NN of_IN CPT1_NP ._SENT Intracellular_JJ localization_NN of_IN CPT1_NP ._SENT The_DT intracellular_JJ location_NN of_IN CPT1_NP was_VBD determined_VBN in_IN CHO-K1_JJ cells_NNS stably_RB expressing_VBG T7-CPT1_JJ using_VBG T7_JJ monoclonal_NN primary_JJ antibodies_NNS ._SENT The_DT location_NN of_IN the_DT endoplasmic_JJ reticulum_NN was_VBD assessed_VBN using_VBG primary_JJ antibodies_NNS to_TO calnexin_NN ._SENT Golgi_NP location_NN was_VBD determined_VBN by_IN the_DT addition_NN of_IN FITC-coupled_NP L._NP culinaris_NN lectin_NN ._SENT MitoTracker_NP dye_NN was_VBD used_VBN to_TO determine_VB the_DT location_NN of_IN the_DT mitochondria_NNS ._SENT Secondary_JJ antibodies_NNS were_VBD coupled_VBN to_TO either_DT FITC_NP or_CC Texas_NP Red_NP ._SENT The_DT yellow_JJ color_NN in_IN merged_JJ images_NNS indicates_VBZ overlap_VB between_IN CPT1_NP and_CC the_DT organelle_NN marker_NN ._SENT Brefeldin_NP A_DT treatment_NN of_IN CHO_NP cells_NNS expressing_VBG T7-CPT1_NP resulted_VBN in_IN a_DT redistribution_NN of_IN CPT1_NP from_IN a_DT large_JJ punctate_JJ region_NN to_TO a_DT more_RBR diffuse_JJ region_NN (_( Figure_NP B_NP )_) ._SENT This_DT implies_VBZ that_IN CPT1_NP synthesizes_VBZ PtdCho_NP in_IN the_DT Golgi_NP apparatus_NN ._SENT Coimmunofluorescence_NP of_IN CPT1_NP and_CC CEPT1_NP with_IN organelle-specific_JJ markers_NNS was_VBD performed_VBN ._SENT CPT1_NP colocalized_VBD with_IN the_DT Golgi-specific_NP L._NP culinaris_NN lectin_NN and_CC was_VBD independent_JJ of_IN the_DT endoplasmic_JJ reticulum_NN and_CC mitochondrial_JJ markers_NNS ._SENT This_DT was_VBD consistent_JJ with_IN the_DT redistribution_NN of_IN CPT1_NP in_IN response_NN to_TO brefeldin_NN A_DT treatment_NN ._SENT The_DT CEPT1_JJ protein_NN colocalized_VBN with_IN the_DT endoplasmic_JJ reticulum_NN marker_NN calnexin_NN and_CC was_VBD not_RB found_VBN colocalized_JJ with_IN the_DT Golgi_NP or_CC mitochondrial_JJ markers_NNS ._SENT The_DT CEPT1-GFP_NP chimera_NN was_VBD also_RB found_VBN to_TO colocalize_VB with_IN the_DT endoplasmic_JJ reticulum_NN resident_NN protein_NN disulfide_NN isomerase_NN (_( our_PP$ unpublished_JJ results_NNS )_) ._SENT Figure_NP 4_CD |_SYM Intracellular_JJ localization_NN of_IN CEPT1_NP ._SENT Intracellular_JJ localization_NN of_IN CEPT1_NP ._SENT The_DT intracellular_JJ location_NN of_IN CEPT1_NP was_VBD determined_VBN in_IN CHO-K1_JJ cells_NNS stably_RB expressing_VBG T7-CEPT1_JJ using_VBG T7_JJ monoclonal_NN primary_JJ antibodies_NNS ._SENT The_DT location_NN of_IN the_DT endoplasmic_JJ reticulum_NN was_VBD assessed_VBN using_VBG primary_JJ antibodies_NNS to_TO calnexin_NN ._SENT Golgi_NP location_NN was_VBD determined_VBN by_IN the_DT addition_NN of_IN FITC_NP coupled_VBD L._NP culinaris_NP lectin_NN ._SENT MitoTracker_NP dye_NN was_VBD used_VBN to_TO determine_VB the_DT location_NN of_IN the_DT mitochondria_NNS ._SENT Secondary_JJ antibodies_NNS were_VBD coupled_VBN to_TO either_DT FITC_NP or_CC Texas_NP Red_NP ._SENT The_DT yellow_JJ color_NN in_IN merged_JJ images_NNS indicates_VBZ overlap_VB between_IN CEPT1_NP and_CC the_DT organelle_NN marker_NN ._SENT Reconstitution_NN of_IN the_DT PtdCho_NP Biosynthetic_NP Pathway_NP |_SYM Closer_NN observation_NN of_IN the_DT merged_JJ CEPT1/calnexin_NP image_NN resulted_VBD in_IN our_PP$ observance_NN of_IN a_DT small_JJ region_NN around_IN the_DT nuclear_JJ membrane_NN that_WDT did_VBD not_RB appear_VB to_TO completely_RB merge_VB with_IN the_DT endoplasmic_JJ reticulum_NN marker_NN ._SENT The_DT synthesis_NN of_IN CDP-choline_NP for_IN consumption_NN by_IN cholinephosphotransferase_NN is_VBZ the_DT rate-limiting_JJ step_NN in_IN the_DT synthesis_NN of_IN PtdCho_NP and_CC is_VBZ catalyzed_VBN by_IN a_DT pair_NN of_IN CTP:phosphocholine_NP cytidylyltransferase_NN (_( CT_NP )_) enzymes_NNS ._SENT CTalpha_NP is_VBZ the_DT main_JJ isoform_NN present_JJ in_IN most_JJS cell_NN types_NNS including_VBG CHO_NP cells_NNS ,_, and_CC upon_IN activation_NN of_IN PtdCho_NP synthesis_NN (_( e.g._FW ,_, through_IN fatty_JJ acid_JJ supplementation_NN )_) CTalpha_NP translocates_VBZ to_TO the_DT nuclear_JJ membrane_NN ._SENT In_IN our_PP$ hands_NNS ,_, activation_NN of_IN CTalpha_NP also_RB resulted_VBD in_IN its_PP$ colocalization_NN to_TO the_DT nuclear_JJ membrane_NN ,_, and_CC this_DT overlapped_VBN with_IN the_DT portion_NN of_IN CEPT1_NP that_WDT did_VBD not_RB colocalize_VB with_IN the_DT endoplasmic_JJ reticulum_NN (_( Figure_NP A_NP )_) ._SENT To_TO ensure_VB that_IN a_DT portion_NN of_IN CEPT1_NP was_VBD indeed_RB associated_VBN with_IN the_DT nuclear_JJ membrane_NN ,_, we_PP separated_VBD CHO-K1_JJ cellular_JJ nuclei_NNS from_IN endoplasmic_JJ reticulum_NN by_IN subcellular_JJ fractionation_NN ._SENT The_DT nuclei_NNS are_VBP clearly_RB separated_VBN from_IN the_DT endoplasmic_JJ reticulum_NN because_IN the_DT endoplasmic_JJ reticulum_NN marker_NN calnexin_NN is_VBZ found_VBN exclusively_RB in_IN the_DT extranuclear_JJ fraction_NN ,_, whereas_IN the_DT nuclear_JJ membrane_NN marker_NN Lap-2_NP is_VBZ found_VBN exclusively_RB in_IN the_DT nuclear_JJ fraction_NN ._SENT Similar_JJ to_TO our_PP$ coimmunofluorescence_NN experiments_NNS ,_, the_DT bulk_NN of_IN CEPT1_NP was_VBD associated_VBN with_IN the_DT extranuclear_JJ fraction_NN ,_, whereas_IN a_DT smaller_JJR proportion_NN was_VBD found_VBN in_IN the_DT nucleus_NN ._SENT These_DT experiments_NNS demonstrate_VBP that_IN CEPT1_NP resides_VBZ in_IN both_CC the_DT endoplasmic_JJ reticulum_NN and_CC nuclear_JJ membranes_NNS ,_, and_CC increasing_VBG PtdCho_NP synthesis_NN via_IN CTalpha_NP translocation_NN is_VBZ by_IN redistribution_NN of_IN this_DT rate-limiting_JJ enzyme_NN to_TO nuclear_JJ located_JJ CEPT1_NN ._SENT However_RB ,_, whether_IN CEPT1_NP and_CC CTalpha_NP reside_VBP within_IN the_DT same_JJ nuclear_JJ membrane_NN and/or_CC directly_RB interact_VB will_MD require_VB further_JJR experimentation_NN ._SENT Figure_NP 5_CD |_SYM PtdCho_NP synthesis_NN pathway_NN reconstitution_NN at_IN the_DT nuclear_JJ membrane_NN ._SENT PtdCho_NP synthesis_NN pathway_NN reconstitution_NN at_IN the_DT nuclear_JJ membrane_NN ._SENT (_( A_NP )_) CHO-K1_NP stably_RB expressing_VBG T7-CEPT1_NP were_VBD treated_VBN with_IN oleic_JJ acid_NN (_( 500_CD muM_NN in_IN 0.5_CD %_NN bovine_JJ serum_NN albumin_NN )_) for_IN 24_CD h_NN to_TO translocate_VB CTalpha_NP from_IN its_PP$ inactive_JJ soluble_JJ intranuclear_JJ location_NN to_TO its_PP$ active_JJ nuclear_JJ membrane_NN location_NN before_IN immunofluorescence_NN ._SENT (_( B_NP )_) Nuclei_NP (_( N_NP )_) were_VBD separated_VBN from_IN extranuclear_JJ structures_NNS including_VBG the_DT endoplasmic_JJ reticulum_NN (_( E_NN )_) by_IN subcellular_JJ fractionation_NN as_IN described_VBN in_IN MATERIALS_NP AND_CC METHODS_NP ,_, and_CC the_DT distribution_NN of_IN nuclear_JJ and_CC endoplasmic_JJ reticulum_NN markers_NNS are_VBP compared_VBN with_IN CEPT1_NP ._SENT Structure/Function_NP Analysis_NP of_IN CEPT1_NP |_SYM The_DT first_JJ genes_NNS identified_VBN to_TO code_VB for_IN cholinephosphotransferase_NN and_CC ethanolaminephosphotransferase_NN activities_NNS were_VBD isolated_VBN from_IN the_DT yeast_NN S._NP cerevisiae_NNS ._SENT The_DT yeast_NN CPT1_JJ gene_NN product_NN utilizes_VBZ CDP-choline_NP in_IN vitro_NP and_CC in_IN vivo_RB ,_, whereas_IN the_DT EPT1_JJ gene_NN product_NN can_MD use_VB both_DT CDP-choline_NP and_CC CDP-ethanolamine_NP ._SENT Genetic_JJ inactivation_NN of_IN the_DT CPT1_NP and_CC EPT1_NP genes_NNS resulted_VBD in_IN the_DT complete_JJ loss_NN of_IN measurable_JJ cholinephosphotransferase_NN and_CC ethanolaminephosphotransferase_NN in_IN vitro_NN enzyme_NN activity_NN and_CC an_DT inability_NN to_TO incorporate_VB specific_JJ radiolabeled_JJ precursors_NNS for_IN each_DT pathway_NN into_IN either_DT PtdCho_NP or_CC PtdEtn_NP ._SENT Inactivation_NN of_IN the_DT both_CC CDP-alcohol_NN pathways_NNS in_IN most_JJS cell_NN types_NNS would_MD be_VB lethal_JJ ;_: however_RB ,_, yeast_NN cells_NNS are_VBP still_RB viable_JJ because_IN they_PP can_MD de_NP novo_NP synthesize_VB phosphatidylserine_NN ,_, which_WDT can_MD be_VB decarboxylated_JJ to_TO PtdEtn_NP and_CC methylated_VBD to_TO PtdCho_NP ._SENT The_DT ability_NN of_IN yeast_NN to_TO survive_VB in_IN the_DT absence_NN of_IN functional_JJ CDP-choline_NP and_CC CDP-ethanolamine_NP pathways_NNS for_IN PtdCho_NP and_CC PtdEtn_NP synthesis_NN allowed_VBN for_IN their_PP$ use_NN as_IN a_DT null_JJ expression_NN system_NN for_IN structure/function_NN analysis_NN of_IN human_JJ CEPT1_NP ._SENT Extrapolation_NN of_IN previous_JJ chimeric_JJ enzyme_NN analysis_NN of_IN the_DT yeast_NN Cpt1p_NP and_CC Ept1p_NP enzymes_NNS to_TO human_JJ CEPT1_JJ positions_NNS the_DT outside_JJ limit_NN of_IN the_DT CDP-alcohol_NP --_: binding_JJ region_NN to_TO amino_NN acid_NN residues_NNS 88_CD --_: 213_CD ,_, whereas_IN the_DT diacylglycerol_NN binding_VBG site_NN is_VBZ located_VBN to_TO the_DT transmembrane_NN helices_NNS spanning_VBG residues_NNS 88_CD --_: 258_NP (_( Figure_NP ;_: ;_: )_) ._SENT Within_IN this_DT region_NN is_VBZ a_DT CDP-alcohol_NP phosphotransferase_NN motif_NN ,_, DG(x)2AR(x)8G(x)3D(x)3D_NP ,_, that_WDT runs_VBZ from_IN residues_NNS 136_CD --_: 158_CD in_IN human_JJ CEPT1_NP ._SENT The_DT final_JJ two_CD aspartates_NNS within_IN this_DT motif_NN are_VBP required_VBN for_IN catalysis_NN with_IN the_DT remainder_NN of_IN the_DT conserved_VBN residues_NNS responsible_JJ for_IN substrate_NN affinity_NN or_CC steric_JJ stability_NN ._SENT Secondary_JJ structure_NN predictions_NNS and_CC hydropathy_NN plots_NNS weave_VBP either_RB three_CD of_IN four_CD membrane-spanning_NN domains_NNS through_IN the_DT substrate_NN binding_VBG region_NN of_IN the_DT yeast_NN and_CC human_JJ cholinephosphotransferases_NNS and_CC choline/ethanolaminephosphotransferases_NNS ._SENT Amino_NN acids_NNS residues_NNS within_IN the_DT CDP-alcohol_NP phosphotransferase_NN motif_NN were_VBD changed_VBN from_IN those_DT found_VBN in_IN the_DT dual_JJ specificity_NN human_JJ CEPT1_NN and_CC yeast_NN Ept1p_NN to_TO those_DT found_VBN in_IN CDP-choline_NP --_: restricted_JJ human_JJ CPT1_NN and_CC yeast_NN Cpt1p_NP (_( Figure_NP A_NP )_) to_TO determine_VB if_IN the_DT divergent_JJ residues_NNS within_IN this_DT region_NN impart_VB CDP-alcohol_NP specificity_NN ._SENT Figure_NP 6_CD |_SYM Predicted_JJ secondary_JJ structures_NNS for_IN human_JJ CEPT1_NP ._SENT Predicted_VBN secondary_JJ structures_NNS for_IN human_JJ CEPT1_NP ._SENT Seven_CD or_CC eight_CD membrane_NN spans_NNS are_VBP strongly_RB predicted_VBN with_IN helix_NN 181_CD --_: 199_CD positioned_VBN either_RB in_IN (_( A_NP )_) or_CC outside_JJ (_( B_NP )_) of_IN the_DT membrane_NN using_VBG the_DT SMART_NP or_CC TmPred_JJ algorithms_NNS ._SENT The_DT numbers_NNS denote_VBP amino_NN acid_NN residues_NNS with_IN the_DT black_JJ filled_VBN circles_NNS representing_VBG those_DT mutated_VBN in_IN the_DT current_JJ study_NN ._SENT Based_VBN on_IN comparisons_NNS to_TO studies_NNS on_IN the_DT yeast_NN Cpt1p_NP and_CC Ept1p_NP enzymes_NNS ,_, the_DT dark_JJ gray_JJ circles_NNS represent_VBP the_DT maximum_JJ region_NN required_VBN for_IN diacylglycerol_NN binding_NN ,_, and_CC the_DT light_JJ gray_NN the_DT maximum_JJ region_NN required_VBN for_IN CDP-alcohol_NP binding_NN ._SENT The_DT conserved_VBN residues_NNS within_IN the_DT CDP-alcohol_NP phosphotransferase_NN motif_NN ,_, DG(x)2AR(x)8G(x)3D(x)3D_NP ,_, are_VBP also_RB indicated_VBN ._SENT Figure_NP 7_CD |_SYM CEPT1_JJ CDP-alcohol_NP phosphotransferase_NN motif_NN mutants_NNS ._SENT CEPT1_NP CDP-alcohol_NP phosphotransferase_NN motif_NN mutants_NNS ._SENT (_( A_NP )_) The_DT site-directed_JJ mutations_NNS made_VBN in_IN CEPT1_NP are_VBP indicated_VBN ._SENT The_DT numbers_NNS denote_VBP CEPT1_JJ amino_NN acid_NN residues_NNS ._SENT (_( B_LS )_) Western_JJ blot_NN of_IN wild-type_NN and_CC mutant_JJ versions_NNS of_IN CEPT1_NP ._SENT CEPT1_NP CDP-Alcohol_NP Site-directed_NP Mutants_NP |_SYM Plasmids_NNS carrying_VBG wild-type_NN and_CC site-directed_JJ mutants_NNS of_IN CEPT1_NP were_VBD transformed_VBN into_IN S._NP cerevisiae_NP HJ091_NP ,_, a_DT yeast_NN strain_NN that_WDT is_VBZ devoid_JJ of_IN cholinephosphotransferase_NN and_CC ethanolaminephosphotransferase_NN activities_NNS due_JJ to_TO inactivating_VBG mutations_NNS within_IN its_PP$ endogenous_JJ CPT1_JJ and_CC EPT1_JJ genes_NNS (_( cpt1::LEU2_JJ ept1-_NN ;_: ;_: ;_: )_) ._SENT This_DT expression_NN system_NN ensures_VBZ that_IN any_DT cholinephosphotransferase_NN or_CC ethanolaminephosphotransferase_NN activity_NN detected_VBD would_MD be_VB plasmid_NN encoded_VBD ._SENT Western_JJ blot_NN analysis_NN of_IN HJ091_JJ membrane_NN fractions_NNS expressing_VBG the_DT wild-type_NN and_CC mutant_JJ versions_NNS of_IN CEPT1_NP established_VBD that_IN similar_JJ amounts_NNS of_IN full-length_JJ enzyme_NN were_VBD being_VBG expressed_VBN (_( Figure_NP B_NP )_) ._SENT The_DT CDP-alcohol_NP specificities_NNS of_IN CEPT1_NP and_CC the_DT CDP-alcohol_NP phosphotransferase_NN motif_NN mutants_NNS were_VBD determined_VBN by_IN in_IN vitro_NN enzyme_NN assay_NN ._SENT There_EX were_VBD very_RB small_JJ differences_NNS in_IN enzyme_NN activity_NN or_CC CDP-alcohol_NN specificity_NN with_IN the_DT CEPT1_NP N144G_NP ,_, S146Q_NP ,_, or_CC S146C_NP mutations_NNS compared_VBN with_IN the_DT wild-type_NN enzyme_NN ._SENT A_DT decrease_NN in_IN both_DT cholinephosphotransferase_NN and_CC ethanolaminephosphotransferase_NN activity_NN to_TO similar50_JJ %_NN wild-type_NN activity_NN was_VBD seen_VBN in_IN the_DT K138_NP M_NP mutant_NN ;_: however_RB ,_, this_DT demonstrates_VBZ an_DT overall_JJ effect_NN on_IN activity_NN but_CC not_RB substrate_NN specificity_NN because_IN use_NN of_IN both_DT CDP-choline_NP and_CC CDP-ethanolamine_NP as_IN substrates_NNS was_VBD equally_RB affected_VBN ._SENT Mutation_NN of_IN glycine_NN 156_CD to_TO either_DT alanine_NN ,_, serine_NN ,_, or_CC cysteine_NN also_RB decreased_VBD cholinephosphotransferase_JJ activity_NN t_NN 